Biotech Startups

microTERRA develops functional food ingredients derived from Lemna (duckweed) that improve flavor and texture, offering a sustainable alternative to conventional ingredient sources. It serves the food industry, targeting formulators, creators, and distributors.

5 investors

MindMed is a biotech company developing psychedelic-based therapeutics, including a proprietary orally disintegrating LSD tablet (DT120) and an R-enantiomer of MDMA (DT402), to treat brain health disorders such as generalized anxiety disorder, major depressive disorder, PTSD, and autism spectrum disorder. Its work targets patients in the U.S. and remains in clinical/preclinical stages, not yet FDA-approved.

5 investors

Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.

5 investors

Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis. It operates in the biotech and drug discovery field focused on DUB biology.

5 investors

Modern Synthesis is a biotechnology company that grows microbially-derived biomaterials from bacterial nanocellulose to replace animal leather and plastic-based synthetic textiles. It serves fashion and luxury brands, combining biology, material science, engineering, and textile craft to produce lower-impact materials.

5 investors

Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification. The company serves researchers and developers in therapeutics, vaccines, immunotherapy, agriculture, and nanotechnology.

5 investors

Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.

5 investors

Mother Science creates biotech-based skincare products featuring Malassezin, a naturally-occurring molecule, for consumers seeking scientifically-validated beauty solutions. The company focuses on efficacious ingredients with rigorous safety standards and excludes common potentially harmful compounds from its formulations.

5 investors

Multiomic Health applies systems biology and data science to omics datasets for drug discovery and development in cardiometabolic and related diseases, working through R&D partnerships with biopharma organizations. The company combines computational biology and translational science to advance therapeutic candidates.

5 investors

MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders. It conducts non-clinical and human clinical studies of low-dose psilocybin, with an initial focus on Premenstrual Dysphoric Disorder and other neuropsychiatric conditions such as OCD, Opioid Use Disorder, and Parkinson's Disease.

5 investors

MyKor is a female-founded company with a team experienced in construction, manufacturing, materials science, engineering and biotechnology. It operates across three sites in the UK and Portugal.

5 investors

Mythic Therapeutics was a clinical-stage biotech developing next-generation antibody-drug conjugates for cancer using its proprietary FateControl technology. Its lead candidate, MYTX-011, targeted cMET in a Phase 1 trial for non-small cell lung cancer.

5 investors

The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications. The company leverages proprietary filamentous fungal strains to engineer high-performance solutions across multiple industries.

5 investors

Neoplants is a plant engineering company working to unlock the biological potential of plants. The site is a pre-launch teaser with minimal detail on specific products.

5 investors

Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders. It focuses on science-driven drug development to address GI conditions that affect patients' quality of life.

5 investors

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system. Founded by neuroscientists and stem cell researchers from UC San Francisco, it operates a regenerative medicine discovery platform and manufactures neuronal, glial, and gene-edited cell therapy candidates in its own cGMP facility.

5 investors

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.

5 investors

NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.

5 investors

Nosh develops food ingredients made from fungal fermentation as a sustainable alternative to animal-derived products, aiming to deliver taste, texture, nutrition and affordability. The company targets the food industry, including the foodservice sector, with ingredient solutions intended to reduce the environmental impact of the food system.

5 investors

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.

5 investors

Novartis is a pharmaceutical company that develops and markets prescription medicines for patients across therapeutic areas including multiple sclerosis, breast cancer, and inflammatory conditions. Its medicines include treatments for HR+/HER2- early breast cancer and polymyalgia rheumatica.

5 investors

NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.

5 investors

Number8 develops solutions to increase productivity and reduce emissions in grass-fed cattle operations and their retail supply chain. The company serves cattle producers and downstream retailers in the food supply industry.

5 investors

Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.

5 investors